|
|
1 | (26) |
|
|
2 | (1) |
|
|
2 | (1) |
|
|
3 | (1) |
|
|
3 | (2) |
|
|
5 | (8) |
|
|
13 | (1) |
|
|
14 | (1) |
|
|
15 | (1) |
|
|
16 | (2) |
|
Development and Approval of New Drugs |
|
|
18 | (2) |
|
Federal Laws Related to Drug Development and Use |
|
|
20 | (2) |
|
Dispensing Versus Prescribing Drugs |
|
|
22 | (1) |
|
|
22 | (1) |
|
Disposal of Unwanted Drugs |
|
|
23 | (4) |
|
2 Routes and Techniques of Drug Administration |
|
|
27 | (24) |
|
|
28 | (1) |
|
|
28 | (6) |
|
Drug Preservatives and Solvents |
|
|
34 | (1) |
|
|
34 | (12) |
|
|
46 | (1) |
|
Dispensed Medication Labeling |
|
|
46 | (1) |
|
|
47 | (1) |
|
|
48 | (3) |
|
|
51 | (17) |
|
|
52 | (1) |
|
|
52 | (1) |
|
|
53 | (2) |
|
|
55 | (2) |
|
|
57 | (1) |
|
|
57 | (2) |
|
|
59 | (1) |
|
Calculations Involving Intravenous Fluid Administration |
|
|
59 | (9) |
|
4 Drugs Used in Nervous System Disorders |
|
|
68 | (31) |
|
|
69 | (1) |
|
|
69 | (4) |
|
|
73 | (3) |
|
Classes of Autonomic Nervous System Agents |
|
|
76 | (1) |
|
|
76 | (1) |
|
Cholinergic Blocking Agents (Anticholinergic) |
|
|
77 | (1) |
|
Adrenergic (Sympathomimetic) Agents |
|
|
78 | (1) |
|
Adrenergic Blocking Agents |
|
|
79 | (1) |
|
|
79 | (1) |
|
|
80 | (2) |
|
|
82 | (2) |
|
|
84 | (1) |
|
|
85 | (2) |
|
|
87 | (1) |
|
|
87 | (1) |
|
Drugs Given to Prevent or Control Seizures |
|
|
87 | (1) |
|
|
88 | (3) |
|
Miscellaneous Central Nervous System Drugs |
|
|
91 | (1) |
|
Central Nervous System Stimulants |
|
|
92 | (1) |
|
Neuromuscular Blocking Drugs |
|
|
92 | (1) |
|
Behavioral Pharmacotherapy |
|
|
93 | (1) |
|
|
93 | (1) |
|
|
94 | (1) |
|
|
95 | (4) |
|
5 Drugs Used in Respiratory System Disorders |
|
|
99 | (14) |
|
|
100 | (1) |
|
Respiratory Anatomy and Physiology |
|
|
100 | (1) |
|
Respiratory Defense Mechanisms |
|
|
101 | (1) |
|
Principles of Respiratory Therapeutics |
|
|
102 | (1) |
|
Inhalation Therapy for Respiratory Disease |
|
|
102 | (1) |
|
Categories of Respiratory Drugs |
|
|
103 | (1) |
|
|
103 | (1) |
|
Mucolytics: Acetylcysteine |
|
|
104 | (1) |
|
Antitussives: Centrally Acting Agents |
|
|
105 | (2) |
|
|
107 | (1) |
|
|
108 | (1) |
|
|
109 | (1) |
|
|
109 | (1) |
|
Miscellaneous Respiratory Drugs |
|
|
110 | (3) |
|
6 Drugs Used in Renal and Urinary Tract Disorders |
|
|
113 | (16) |
|
|
114 | (1) |
|
|
115 | (2) |
|
|
117 | (1) |
|
Drugs Commonly Used for the Treatment of Renal Dysfunction and Associated Hypertension |
|
|
117 | (1) |
|
|
117 | (3) |
|
|
120 | (1) |
|
|
120 | (1) |
|
|
121 | (1) |
|
Angiotensin-Converting Enzyme Inhibitors |
|
|
121 | (1) |
|
Vasodilators and Calcium Channel Blockers |
|
|
122 | (1) |
|
|
122 | (1) |
|
|
122 | (1) |
|
Xanthine Oxidase Inhibitors |
|
|
123 | (1) |
|
|
123 | (1) |
|
Pharmacotherapy of Renal Failure Complications |
|
|
123 | (1) |
|
Pharmacotherapy of Urinary Incontinence |
|
|
123 | (2) |
|
Miscellaneous Renal Drugs |
|
|
125 | (1) |
|
|
126 | (3) |
|
7 Drugs Used in Cardiovascular System Disorders |
|
|
129 | (19) |
|
|
130 | (1) |
|
Anatomy and Physiology of the Heart |
|
|
130 | (3) |
|
Compensatory Mechanisms of the Cardiovascular System |
|
|
133 | (2) |
|
Basic Objectives in the Treatment of Cardiovascular Disease |
|
|
135 | (1) |
|
Categories of Cardiovascular Drugs |
|
|
135 | (1) |
|
|
135 | (2) |
|
|
137 | (4) |
|
|
141 | (2) |
|
|
143 | (1) |
|
Dietary Management of Heart Disease |
|
|
144 | (1) |
|
Ancillary Treatment of Heart Failure |
|
|
144 | (4) |
|
8 Drugs Used in Gastrointestinal System Disorders |
|
|
148 | (22) |
|
|
149 | (1) |
|
|
149 | (3) |
|
Regulation of the Gastrointestinal System |
|
|
152 | (1) |
|
|
152 | (2) |
|
|
154 | (1) |
|
|
155 | (2) |
|
|
157 | (3) |
|
|
160 | (1) |
|
Antidiarrheal Medications |
|
|
160 | (1) |
|
|
161 | (2) |
|
Gastrointestinal Prokinetics/Stimulants |
|
|
163 | (1) |
|
|
164 | (1) |
|
Miscellaneous Gastrointestinal Drugs |
|
|
165 | (2) |
|
|
167 | (3) |
|
9 Drugs Used in Hormonal, Endocrine, and Reproductive Disorders |
|
|
170 | (24) |
|
|
171 | (1) |
|
|
171 | (4) |
|
Hormonal Drugs Associated with Reproduction |
|
|
175 | (1) |
|
Gonadotropins and Gonadal Hormones |
|
|
175 | (3) |
|
|
178 | (1) |
|
Drugs That Affect Uterine Contractility |
|
|
179 | (1) |
|
Miscellaneous Reproductive Drugs |
|
|
180 | (1) |
|
|
181 | (1) |
|
|
181 | (1) |
|
Drugs Used to Treat Hypothyroidism |
|
|
182 | (1) |
|
Drugs Used to Treat Hyperthyroidism |
|
|
182 | (1) |
|
Drugs Used to Treat Hyperadrenocorticism (Cushing's Syndrome) |
|
|
183 | (1) |
|
Agents for the Treatment of Diabetes Mellitus |
|
|
184 | (4) |
|
|
188 | (1) |
|
Hormones That Act as Growth Promoters |
|
|
188 | (1) |
|
Sex Steroids, Synthetic Steroid Analogues, and Nonsteroidal Analogues |
|
|
188 | (1) |
|
Growth Hormone: Bovine Somatotropin, Bovine Growth Hormone |
|
|
189 | (1) |
|
|
190 | (4) |
|
10 Drugs Used in Ophthalmic and Otic Disorders |
|
|
194 | (18) |
|
|
195 | (1) |
|
|
196 | (2) |
|
|
198 | (1) |
|
|
198 | (1) |
|
|
199 | (1) |
|
Beta-Adrenergic Antagonists |
|
|
200 | (1) |
|
Carbonic Anyhydrase Inhibitors |
|
|
200 | (1) |
|
|
200 | (1) |
|
Osmotic Agents for the Treatment of Glaucoma |
|
|
201 | (1) |
|
Mydriatic Cycloplegic Vasoconstrictors |
|
|
201 | (1) |
|
Antiinflammatory/Analgesic Ophthalmic Agents |
|
|
202 | (1) |
|
Nonsteroidal Anatiinflammatory Agents |
|
|
202 | (1) |
|
Steroidal Antiinflammatory Agents |
|
|
203 | (1) |
|
|
203 | (1) |
|
Antimicrobial Ophthalmic Therapy |
|
|
204 | (1) |
|
Miscellaneous Ocular Antibiotics |
|
|
205 | (1) |
|
|
205 | (1) |
|
|
206 | (1) |
|
Drugs for Keratoconjunctivitis Sicca |
|
|
207 | (1) |
|
Ocular Lubricants/Artificial Tear Products |
|
|
207 | (1) |
|
|
207 | (1) |
|
|
207 | (5) |
|
11 Drugs Used in Skin Disorders |
|
|
212 | (17) |
|
|
213 | (1) |
|
|
213 | (2) |
|
|
215 | (1) |
|
Topical Antipruritics and Antiinflammatories |
|
|
215 | (4) |
|
|
219 | (2) |
|
|
221 | (1) |
|
|
222 | (3) |
|
|
225 | (1) |
|
Topical Antiparasitic Agents |
|
|
225 | (4) |
|
|
229 | (39) |
|
|
231 | (1) |
|
|
231 | (1) |
|
|
232 | (3) |
|
|
235 | (1) |
|
|
236 | (5) |
|
|
241 | (1) |
|
|
242 | (5) |
|
|
247 | (2) |
|
|
249 | (2) |
|
|
251 | (2) |
|
|
253 | (1) |
|
|
254 | (4) |
|
|
258 | (2) |
|
|
260 | (2) |
|
Disinfectants/Antiseptics |
|
|
262 | (6) |
|
|
268 | (28) |
|
|
269 | (1) |
|
|
270 | (1) |
|
|
270 | (9) |
|
|
279 | (1) |
|
|
279 | (1) |
|
|
279 | (1) |
|
|
280 | (1) |
|
|
281 | (1) |
|
|
281 | (2) |
|
|
283 | (1) |
|
|
284 | (1) |
|
|
284 | (6) |
|
|
290 | (6) |
|
14 Drugs Used to Relieve Pain and Inflammation |
|
|
296 | (23) |
|
|
297 | (2) |
|
|
299 | (2) |
|
Nonsteroidal Antiinflammatory Drugs |
|
|
301 | (4) |
|
Other Nonsteroidal Antiinflammatory Drugs |
|
|
305 | (2) |
|
|
307 | (1) |
|
Other Drugs Used as Pain Control Agents |
|
|
308 | (1) |
|
|
309 | (1) |
|
|
310 | (1) |
|
|
311 | (3) |
|
Local, Regional, and Topical Anesthetic Agents |
|
|
314 | (5) |
|
15 Therapeutic Nutritional, Fluid, and Electrolyte Replacements |
|
|
319 | (29) |
|
|
320 | (1) |
|
Anatomy, Physiology, and Chemistry |
|
|
320 | (4) |
|
Principles of Fluid Therapy |
|
|
324 | (9) |
|
Types of Solutions Used in Fluid Therapy |
|
|
333 | (1) |
|
|
334 | (2) |
|
Isotonic High-Sodium Crystalloids |
|
|
336 | (1) |
|
Hypotonic Low-Sodium Crystalloids |
|
|
336 | (1) |
|
Hypertonic Saline Solutions |
|
|
337 | (1) |
|
|
337 | (2) |
|
|
339 | (3) |
|
Oral Electrolyte Preparations |
|
|
342 | (1) |
|
|
343 | (1) |
|
Parenteral Vitamin/Mineral Products |
|
|
343 | (1) |
|
|
343 | (1) |
|
|
344 | (4) |
|
16 Blood-Modifying, Antineoplastic, and Immunosuppressant Drugs |
|
|
348 | (24) |
|
|
349 | (1) |
|
Blood-Modifying Drugs/Agents |
|
|
349 | (1) |
|
|
349 | (2) |
|
|
351 | (3) |
|
Hemostatics/Anticoagulant Antagonists |
|
|
354 | (2) |
|
Fibrinolytic (Thrombolytic) Drugs |
|
|
356 | (1) |
|
|
356 | (1) |
|
Principles of Chemotherapy |
|
|
357 | (1) |
|
|
358 | (2) |
|
|
360 | (3) |
|
|
363 | (1) |
|
|
364 | (1) |
|
Miscellaneous Antineoplastic Drugs |
|
|
364 | (1) |
|
Biologic Response Modifiers |
|
|
365 | (2) |
|
|
367 | (5) |
|
|
372 | (19) |
|
Principles of Vaccination |
|
|
373 | (1) |
|
Common Vaccine Types That Produce Active Immunity |
|
|
374 | (1) |
|
|
374 | (1) |
|
|
374 | (1) |
|
|
375 | (1) |
|
|
375 | (1) |
|
|
376 | (1) |
|
Common Vaccine Types That Produce Passive Immunity |
|
|
376 | (1) |
|
|
376 | (1) |
|
|
376 | (1) |
|
|
377 | (1) |
|
|
377 | (1) |
|
|
377 | (1) |
|
Administration of Vaccines |
|
|
377 | (1) |
|
Biologic Care and Vaccine Failure |
|
|
378 | (1) |
|
Adverse Vaccination Responses |
|
|
379 | (1) |
|
Vaccinations for Preventive Health Programs |
|
|
379 | (9) |
|
|
388 | (1) |
|
|
388 | (3) |
|
18 Miscellaneous Therapeutic Agents |
|
|
391 | (17) |
|
|
392 | (1) |
|
|
392 | (1) |
|
|
392 | (2) |
|
|
394 | (2) |
|
|
396 | (3) |
|
|
399 | (4) |
|
|
403 | (2) |
|
|
405 | (3) |
|
19 Inventory: The Veterinary Technician's Role |
|
|
408 | (19) |
|
|
409 | (1) |
|
|
409 | (3) |
|
|
412 | (1) |
|
|
412 | (1) |
|
|
412 | (1) |
|
Proactive Inventory Control System |
|
|
413 | (1) |
|
|
414 | (1) |
|
|
414 | (4) |
|
|
418 | (2) |
|
|
420 | (1) |
|
|
420 | (4) |
|
|
424 | (1) |
|
The Job of Inventory Control Manager |
|
|
425 | (2) |
Appendix A Common Abbreviations Used in Veterinary Medicine |
|
427 | (2) |
Appendix B Weights and Measures |
|
429 | (4) |
Appendix C Antidotes |
|
433 | (9) |
Appendix D Common Drugs: Approximate Dosages |
|
442 | (43) |
Appendix E Listing of Drugs According to Functional and Therapeutic Classification |
|
485 | (8) |
Appendix F Controlled Substances Information Summary |
|
493 | (3) |
Bibliography |
|
496 | (2) |
Glossary |
|
498 | (8) |
Index |
|
506 | |